Apton Biosystems logo — Innovative optical system for superior sequencing and protei...

Apton Biosystems

Innovative optical system for superior sequencing and protein detection, enabling early disease detection and precision medicine advancements.

Founded 2012 11-50 employees Series A Total: $31.61M Biotechnology, Health Care

General Information

Company Name Apton Biosystems
Founded Year 2012
Employees 11-50
Industries Biotechnology, Health Care
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Apton Biosystems. To contact Apton Biosystems, visit aptonbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Apton Biosystems compare?

A PDF of Apton Biosystems and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Apton Biosystems soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Apton Biosystems

Apton Biosystems is a biotechnology startup founded in 2012, specializing in an innovative optical system for superior sequencing and protein detection. Their technology employs super-resolution to evaluate molecules positioned closer than a wavelength of light, enabling early disease detection and precision medicine advancements. This breakthrough has significant potential in biomarker discovery, early disease detection, and therapeutic monitoring, thereby enhancing preventive health and precision medicine. Apton Biosystems recently received a significant $24.60M Series A investment on 29 April 2021, with participation from esteemed investors including Casdin Capital, Khosla Ventures, and Kern Capital. This substantial investment underlines the confidence of these prominent investors in Apton Biosystems' potential to revolutionize the field of biotechnology and contribute to scientific and medical advancements.

Business keywords: biomarker discovery, protein detection, optical system, super-resolution technology, early disease detection, therapeutic monitoring, precision medicine, preventive health, molecular evaluation, sequencing technology

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $24.60M 3
Casdin Capital, Khosla Ventures +1
29 Apr 2021
Venture Round $7.01M 1
Khosla Ventures
12 Mar 2015

Apton Biosystems Alternatives & Competitors

View All Alternatives
Apton Biosystems vs
BioLum Sciences
BioLum Sciences United States

Transforming Precision Drug Discovery and Early Detection of Disease

Grant
5 employees
Biotechnology, Digital Health
Apton Biosystems vs
NanoMosaic Inc.
NanoMosaic Inc. United States

Next generation proteomics and multi-omics powered by nanoneedles

Series A
15 employees
Biopharma, Biotechnology
Apton Biosystems vs

Make Personalized Medicine Accessible To All.

Venture round
121 employees
Biotechnology, Health Care

FAQ About Apton Biosystems

Innovative optical system for superior sequencing and protein detection, enabling early disease detection and precision medicine advancements.
Apton Biosystems was founded in 2012.
Apton Biosystems operates in Biotechnology and Health Care. Its work centres on biomarker discovery, protein detection, optical system and super-resolution technology.
Apton Biosystems has approximately 11-50 employees.
Apton Biosystems has completed 2 funding rounds, raising a total of $31.61M. The latest funding stage is Series A.
Top alternatives and competitors to Apton Biosystems include BioLum Sciences, NanoMosaic Inc., ACT Genomics, Predicine, HAWK Biosystems. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Apton Biosystems and BioLum Sciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Apton Biosystems, https://bouncewatch.com/company/apton-biosystems, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes